HEALTH (ALT)

Defeat Lyme disease without antibiotics

(NaturalNews) Let’s be blunt: Western medicine will never really cure Lyme disease because the focus (like everything they do) is on symptoms, not the underlying cause. In fact, sadly, if you’ve been suffering with Lyme disease for some time, you’ve probably been labeled with a mental…

Melted fuel from Fukushima disaster still missing

(NaturalNews) An earthquake triggered a Tsunami that rocked the Fukushima Daiichi nuclear power plant on Japan’s Tohoku coast in March, 2011, causing the near destruction of three nuclear power plants. It’s been four years since the Fukushima disaster, and experts have yet to pinpoint…

KWN HEALTH

HEALTH (MSM)

Alstom to take 300 million euro hit to help GE sale through

Alstom is to accept a 300 million euro ($333 million) reduction in the price it will get for selling its power turbines unit to General Electric as a contribution to the U.S. firm’s efforts to get antitrust clearance in Europe. “In order to support General Electric in its offering of a comprehensive set of remedies addressing the concern of the(European) Commission, Alstom’s board… would contribute financially to such remedy package

Sanofi says new data analyses support its dengue vaccine

French drugmaker Sanofi said on Monday that new data analyses published in the New England Journal of Medicine confirmed that its vaccine candidate against dengue protected two-thirds of the participants in two late-stage studies. Protection against severe dengue reached 93 percent, while prevention of hospitalization due to the disease reached 80 percent in the volunteers, who were aged nine and above, Sanofi said in a statement. “The dengue vaccine candidate

Teva to buy Allergan generic drug business for $40.5 billion, drops Mylan bid

By Tova Cohen and Steven Scheer TEL AVIV (Reuters) – Teva Pharmaceutical Industries has agreed to buy Allergan Plc’s generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world’s largest pharmaceutical firms. The deal, the largest in Israel’s corporate history, prompted Teva to drop its $40 billion hostile bid for Mylan, which used a poison pill-style defense